Adults with hidradenitis suppurativa treated with adalimumab have a greater risk for serious infections than those with ...

GLP-1 receptor agonists show promise in treating hidradenitis suppurativa, offering significant symptom relief and improved ...

A multicenter French study led by Rennes University Hospital reports potential benefits of glucagon-like peptide-1 receptor ...

Discover a study exploring how GLP-1 receptor agonists may reduce symptoms of hidradenitis suppurativa through weight loss and anti-inflammatory effects.

Incyte Corporation (($CC:INCY.CUR)) announced an update on their ongoing clinical study. Incyte Corporation recently completed a Phase 2 clinical ...

In this retrospective study, patients who started a GLP-1 agonist experienced significant declines in hidradenitis ...

Panelists discuss the critical importance of early biologic therapy initiation in hidradenitis suppurativa to prevent irreversible tissue damage, reduce disease burden, and overcome socioeconomic and ...

Glucagon-like peptide-1 (GLP-1) receptor agonists show promise in reducing hidradenitis suppurativa severity and pain, especially in patients with obesity.

Discover a study validating a disease-specific quality-of-life tool for hidradenitis suppurativa, confirming its reliability, ...

Hidradenitis suppurativa patients face higher depression and anxiety risks, but biologic treatments may reduce these mental ...

Hidradenitis suppurativa generally causes inflamed, discolored, swollen bumps that can fill with pus and break open. Sometimes, the condition can also cause scarring and tunneling under your skin.